Relevant bibliographies by topics / Diabetes Mellitus

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Diabetes Mellitus'

Author: Grafiati
Published: 4 June 2021
Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Diabetes Mellitus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Diabetes Mellitus"

1

Doamekpor, Caleb. "Diabetes Mellitus." Acta Scientific Pharmaceutical Sciences 4, no. 2 (January 31, 2020): 01–09. http://dx.doi.org/10.31080/asps.2020.04.diabetes-mellitus.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Begum, SA, R. Afroz, Q. Khanam, A. Khanom, and TS Choudhury. "Diabetes Mellitus and Gestational Diabetes Mellitus." Journal of Paediatric Surgeons of Bangladesh 5, no. 1 (June 30, 2015): 30–35. http://dx.doi.org/10.3329/jpsb.v5i1.23887.

Full text
Abstract:
Diabetes mellitus (DM), also known as simply diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period. Worldwide in 2012 and 2013 diabetes resulted in 1.5 to 5.1 million deaths per year, making it the 8th leading cause of death. Diabetes overall at least doubles the risk of death. This high blood sugar produces the symptoms of frequent urination, increased thirst, and increased hunger. Untreated, diabetes can cause many complications. Acute complications include diabetic ketoacidosis and nonketotic hyperosmolar coma. Serious long-term complications include heart disease, stroke, kidney failure, foot ulcers and damage to the eyes. The number of people with diabetes is expected to rise to 592 million by 2035. The economic costs of diabetes globally were estimated in 2013 at $548 billion and in the United States in 2012 $245 billion. [3]Globally, as of 2013, an estimated 382 million people have diabetes worldwide, with type 2 diabetes making up about 90% of the cases. This is equal to 8.3% of the adults’ population, with equal rates in both women and men. There are three main types of diabetes mellitus: In case of type 1 Diabetes mellitus, results from the body’s failure to produce enough insulin. This form was previously referred to as “insulin-dependent diabetes mellitus” (IDDM) or “juvenile diabetes”. The cause is unknown. Another type is type 2 diabetes mellitus begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses a lack of insulin may also develop. This form was previously referred to as “non insulin-dependent diabetes mellitus” (NIDDM) or “adult-onset diabetes”. The primary cause is excessive body weight and not enough exercise. Gestational diabetes is the third main form and occurs when pregnant women without a previous history of diabetes develop a high blood glucose level. Gestational diabetes usually resolves after the birth of the baby. It occurs in about 2–10% of all pregnancies and may improve or disappear after delivery. However, after pregnancy approximately 5–10% of women with gestational diabetes are found to have diabetes mellitus, most commonly type 2. Gestational diabetes is fully treatable, but requires careful medical supervision throughout the pregnancy.J. Paediatr. Surg. Bangladesh 5(1): 30-35, 2014 (January)
APA, Harvard, Vancouver, ISO, and other styles
3

GÜRBÜZ, Murat, and Menşure Nur ÇELİK. "Minerals and Diabetes Mellitus." Turkiye Klinikleri Journal of Internal Medicine 4, no. 2 (2019): 71–83. http://dx.doi.org/10.5336/intermed.2018-64388.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chaudhary, Nitin, and Nidhi Tyagi. "Diabetes mellitus: An Overview." International Journal of Research and Development in Pharmacy & Life Sciences 7, no. 4 (August 2018): 3030–33. http://dx.doi.org/10.21276/ijrdpl.2278-0238.2018.7(4).3030-3033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ambulkar, Sunil, Parimal Tayde, Makarand Randive, and Mukund Ganeriwal. "Diabetes mellitus in pregnancy." New Indian Journal of OBGYN 4, no. 1 (July 2017): 4–9. http://dx.doi.org/10.21276/obgyn.2017.4.1.2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hornová, Markéta, Patrik Šimják, and Kateřina Anderlová. "Preeclampsia and diabetes mellitus." Česká gynekologie 88, no. 6 (December 20, 2023): 467–71. http://dx.doi.org/10.48095/cccg2023467.

Full text
Abstract:
Objective: The purpose of this paper is to provide a review of recent research on the relationship between preeclampsia and diabetes mellitus in pregnancy. Methodology: A structured search for literary sources in PubMed and ScienceDirect databases using keywords, followed by a selection of papers based on solid methodology. Results: Preeclampsia is a serious condition, which complicates 2–7% of pregnancies. It causes maternal complications (organ dysfunction) and fetal complications (pathological haemodynamic parameters of the uteroplacental unit and fetal growth restriction). Pregnant women with pregestational diabetes have a 2- and 4-times higher risk of developing preeclampsia and the ones with gestational diabetes have 1.3-times higher risk. The main identified risk factors are inadequate compensation of diabetes, diabetic nephropathy, retinopathy and the duration of diabetes. To minimalize the risk of developing preeclampsia, a composite screening has been implemented. With a positive result a preventive use of acetylsalicylic acid from at the latest 16 and up until the 36th week is advised. Preeclampsia is also a risk factor for developing diabetes mellitus and other cardiovascular diseases later in life. For that reason, a long-term dispensary of women who had preeclampsia in pregnancy is recommended. Key words: preeclampsia – proteinuria – pregestational diabetes mellitus – gestational diabetes mellitus – uteroplacental insufficiency – acetylsalicylic acid – late complications of preeclampsia
APA, Harvard, Vancouver, ISO, and other styles
7

Anderlová, Kateřina. "Screening for gestational diabetes mellitus." Vnitřní lékařství 67, no. 6 (October 13, 2021): 366–67. http://dx.doi.org/10.36290/vnl.2021.094.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Anderlová, Kateřina. "Screening for gestational diabetes mellitus." Vnitřní lékařství 67, no. 6 (October 13, 2021): 366–67. http://dx.doi.org/10.36290/vnl.2021.094.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Daidano, Jeando Khan, Nazia Azam Yusfani, and Bilqees Daidano. "DIABETES MELLITUS." Professional Medical Journal 25, no. 06 (June 9, 2018): 881–86. http://dx.doi.org/10.29309/tpmj/18.4535.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Siswoko, Siswoko, Cipto Cipto, and Teguh Wahyudi. "Risiko Preeklamsi Pada Ibu Hamil dengan Penyakit Penyerta." Jurnal Studi Keperawatan 3, no. 1 (March 22, 2022): 22–27. http://dx.doi.org/10.31983/j-sikep.v3i1.8371.

Full text
Abstract:
Latar belakang : Salah satu penyebab utama kematian Ibu di Indonesia disamping perdarahan adalah preeklamsia atau eklamsia. Kejadian preeklamsi belum diketahui secara jelas factor penyebabnya, namun kondisi tersebut sering dijumpai pada ibu hamil dengan riwayat penyakit penyerta seperti diabetes mellitus dan hipertensi.Tujuan : Studi ini menganalisa tentang seberasa besar risiko ibu hamil dengan penyakit penyerta (diabeter mellitus dan atau hipertensi) mengalami preeklamsi.Metode : studi ini menggunakan penelitian analitik kasus kontrol yang merupakan salah satu bentuk rancangan penelitian analitik dengan pendekatan waktu retrospektif dengan mengobservasi 600 data proses perjalanan penyakit hipertensi, diabetes mellitus dan kejadian preeklamsia pada ibu bersalin ke arah belakang tanpa melakukan intervensi.Hasil : Hasil penelitian menunjukkan dua variabel yang bermakna menjadi faktor pencetus terjadinya preeklamsia pada ibu bersalin yaitu riwayat hipertensi (OR = 2,149; CI= 95%) riwayat diabetus mellitus (OR = 6,682 ; CI = 95%).Kesimpulan : Ibu hami dengan penyakit penyerta hipertensi berisiko 2,149 kali mengalami preeklamsi dibandingan dengan ibu hamil tanpa hipertensi. Ibu hamil dengan diabetes mellitus berisiko 6,682 kali mengalami preeklamsi dibandingkan dengan ibu hamil tanpa penyakit penyerta diabetes mellitus. Keywords: preeklamsi, ibu hamil, hipertensi, diabetes melitus
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Diabetes Mellitus"

1

Sousa, Sofia Alexandra. "Diabetes Mellitus felina." Master's thesis, Universidade de Évora, 2022. http://hdl.handle.net/10174/30830.

Full text
Abstract:
O estágio curricular do Mestrado Integrado em Medicina Veterinária da Universidade de Évora realizado durante seis meses no Hospital Veterinário de São Bento, em Lisboa, deu origem ao presente relatório. Este relatório é constituído por duas partes. Na primeira parte fez-se uma breve análise descritiva dos casos clínicos assistidos durante o período de estágio, abordando de forma sumária as patologias mais relevantes para a estagiária. Por sua vez, a segunda parte compreende uma monografia com o tema “Diabetes Mellitus Felina”, onde se realizou uma revisão bibliográfica abordando a fisiologia do pâncreas, a classificação da afeção, a etiologia e patofisiologia, a epidemiologia, a apresentação clínica, o diagnóstico, o tratamento, as complicações associadas, a monitorização e o prognóstico. A Diabetes Mellitus é uma doença endócrina comum no paciente felino que é identificada pela presença de sinais clínicos típicos. Por fim, foi apresentado um caso clínico num gato sendo realizada uma discussão do mesmo; Abstract: Feline Diabetes Mellitus The internship of the master’s degree in Veterinary medicine from the University of Évora, was held for six months at Hospital Veterinário São Bento, in Lisbon, and resulted in the present report. This report consists of two parts. The first part, was held a brief descriptive analysis of clinical cases assisted during the probationary period, briefly addressing the most relevant pathologies for the intern. In turn, the second part is comprised of the monography with the theme Feline Diabetes Mellitus, where a literature review was carried out addressing physiology of the pancreas, classification of the disease, etiology and pathophysiology, epidemiology, clinical presentation, diagnosis, treatment, associated complications, monitoring and prognosis. Diabetes Mellitus is a common endocrine disease in feline patients that is identified by specific clinical signals. Lastly, a clinical case in a cat was presented and a discussion was carried out.
APA, Harvard, Vancouver, ISO, and other styles
2

Grou, Isabel Maria Lampreia. "Diabetes mellitus em canídeos." Bachelor's thesis, Universidade Técnica de Lisboa. Faculdade de Medicina Veterinária, 2008. http://hdl.handle.net/10400.5/900.

Full text
Abstract:
Dissertação de Mestrado Integrado em Medicina Veterinária
A diabetes mellitus é uma insuficiência absoluta ou relativa de insulina que resulta da deficiente secreção desta por parte das células pancreáticas ou da oposição à acção da insulina. A diabetes é uma das endocrinopatias mais frequentes no cão. Quando é diagnosticado com diabetes mellitus, o animal pode encontrar-se num estado dependente de administração exógena de insulina de insulina, em que as células já não produzem insulina, ou num estado de não dependente de insulina, em que as células ainda possuem alguma função residual. No cão, a diabetes mellitus dependente de insulina é uma patologia multifactorial. Alguns dos factores implicados na etiologia da doença são: predisposição genética, infecção, patologia que provoque antagonismo à insulina, fármacos, obesidade, insulite imunomediada e pancreatite. Todos os factores referidos desempenham um papel que culmina na perda de função das células , hipoinsulinemia, deficiência no transporte da glucose para o interior das células e aceleração do processo de gluconeogénese hepática e glicogenólise. A insuficiência em insulina provoca a diminuição da utilização da glucose, levando a hiperglicemia. A glucose, como é uma molécula pequena, é filtrada pelo glomérulo renal; quando a capacidade de reabsorção de glucose das células dos túbulos renais a partir do filtrado glomerular é excedida, ocorre glicosúria. A glicosúria provoca diurese osmótica, que leva a polidipsia. Como a entrada da glucose nas células do centro da saciedade é mediada pela insulina, o centro da saciedade não inibe o centro da alimentação. Os quatro sinais clássicos de diabetes são então poliúria, polidipsia, polifagia e perda de peso. O principal objectivo da terapêutica instituída é eliminar os sinais clínicos observados pelo dono, o que pode ser conseguido com uma administração ponderada de insulina, dieta, exercício e com a prevenção ou controlo de doenças inflamatórias, infecciosas, neoplásicas e endócrinas. As complicações mais frequentes são cegueira devido à formação de cataratas, pancreatite crónica e infecções recorrentes do tracto urinário, das vias respiratórias e da pele. Os animais diabéticos têm ainda o risco de desenvolver hipoglicemia e cetoacidose. A cetoacidose diabética é consequência da diabetes que resulta em formação de corpos cetónicos no fígado, em acidose metabólica, desidratação severa, choque e possivelmente morte. A maior parte dos cães diabéticos vive menos de 5 anos após o diagnóstico, sendo que os primeiros seis meses são decisivos para o controlo da doença. Com cuidados apropriados por parte dos donos, avaliações regulares por parte do veterinário e uma boa comunicação entre o cliente e o médico veterinário, muitos animais diabéticos podem levar vidas relativamente normais durante vários anos.
ABSTRACT - Diabetes mellitus, which is a very common endocrinopathy in the dog, is an absolute or relative insufficiency in the production of insulin by the pancreatic cells or an impaired sensitivity to the hormone or both. When diagnosed with diabetes mellitus some animal may need insulin therapy immediately, for their cells produce no insulin - insulin dependent diabetes mellitus, and some others may have a slower loss of function of cells - non-insulin dependent diabetes mellitus. The etiology of insulin dependent diabetes mellitus in the dog is multifactorial, being related to genetic susceptibility, infections, insulin resistance inducing disease, drugs, obesity, immune mediated insulitis and pancreatitis. All these factors lead to the functional loss of pancreatic cells, impaired transport of glucose into cells and enhancing the hepatic gluconeogenesis and glycogenolisis. The classic clinical signs of diabetes mellitus are polyuria, polydipsia, polyphagia and weight loss. The insulin deficiency leads to a decrease in glucose use and sequent hyperglycemia. Being a small molecule, glucose is filtrated in the renal glomérulos; when the ability of reabsorbing glucose of the tubular cells is overwhelmed, glycosuria occurs. Glycosuria leads to osmotic diuresis, which in turn leads to polydipsia. To enter the satiety center cells, glucose needs insulin. Without it, the satiety center never inhibits the hunger center. The treatment of diabetes aims to control the clinical signs described, and that con be achieved with insulin therapy, diet, exercise and prophylaxis and control of infectious, inflammatory, neoplastic or endocrine diseases. The most frequent consequences of diabetes mellitus in dogs are blindness as a consequence of diabetic cataracts, chronic pancreatitis and urinary tract, skin and upper respiratory tract infections. Diabetic dogs have an increased risk of developing hypoglycemia and ketoacidosis. Ketoacidosis leads to hepatic production of ketone bodies, metabolic acidosis, severe dehydration and even death. Most diabetic dogs live up to 5 years after they are diagnosed, the six first months being the most important ones. With proper care from the owner, regular reevaluations with the veterinarian and good communication between veterinarian and owner, the diabetic dog can have an ordinary life for several years.
APA, Harvard, Vancouver, ISO, and other styles
3

Nordwall, Maria. "Long term complications in juvenile diabetes mellitus." Doctoral thesis, Linköping : Univ, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-6377.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Beales, Philip Edward. "Diabetes prevention in the non-obese diabetic mouse." Thesis, University of East London, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.265059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Paradis, Hilje K. "Osmoregulation in uncontrolled diabetes mellitus." Thesis, University of Ottawa (Canada), 1991. http://hdl.handle.net/10393/7568.

Full text
Abstract:
In this thesis we studied the influence of osmotic loading on vasopressin secretion and water intake in experimentally-induced diabetes mellitus, in the insulin deprived state as well as when treated with insulin, in order to investigate whether the osmotic drive for vasopressin release and thirst is altered in the diabetic state. Four dogs were used for the experiments to be reported. They were infused with hypertonic sodium sulfate to investigate the influence of osmotic loading on water intake and vasopressin secretion in the control, insulin-treated diabetic and diabetic conditions. Forty-eight hours of insulin depletion did not produce a change in the basal plasma vasopressin levels, even though there was a significant increase in plasma osmolality. In addition, forty-eight hours of insulin depletion did not alter the sensitivity of the osmoreceptors controlling vasopressin release and thirst. The effect of the diabetic condition on the osmotic threshold is subject to interpretation of the data. If glucose is considered an osmotically effective solute in the diabetic state, there is an upward resetting of the osmostat for vasopressin release and thirst, and a downward or leftward shift of the osmostat when glucose is not considered to be effective osmotically. The results of the present study provide evidence that the osmotic sensitivity of vasopressin release and thirst is not affected by the presence or absence of insulin. However, whether there is a true resetting of the osmostat for vasopressin release and thirst in the diabetic state depends on the assumption mode concerning glucose permeability.
APA, Harvard, Vancouver, ISO, and other styles
6

Pinto, Mariana de Carvalho [UNESP]. "Parâmetros Neuropáticos no Diabetes Mellitus." Universidade Estadual Paulista (UNESP), 2014. http://hdl.handle.net/11449/123212.

Full text
Abstract:
Made available in DSpace on 2015-05-14T16:53:08Z (GMT). No. of bitstreams: 0 Previous issue date: 2014-12-05Bitstream added on 2015-05-14T16:59:23Z : No. of bitstreams: 1 000823511.pdf: 283504 bytes, checksum: 38d7295662309f22f82f5bf9f3013361 (MD5)
A neuropatia diabética é caracterizada por uma síndrome clínica ou sub -clínica que afeta o sistema nervoso central e periférico, incluindo o autonômico. Frente ao crescente número de novos casos de diabetes mellitus e a elevada incidência de manifestações crônico - degenerativas, como a neuropatia periférica e a neuropatia autonômica cardiovascular, este estudo objetivou: a) fazer uma comparação da variabilidade cardíaca (VC), em indivíduos com diabetes mellitus tipo 2 com confirmação de neuropatia diabética periférica, e indivíduos saudáveis.; b) identificar o risco de queda através de um teste de mobilidade fun cional em não diabéticos, diabéticos neuropatas e diabéticos neuropata -vasculopatas. Para tanto, no primeiro estudo participaram 108 indivíduos divididos em grupo controle (GC) (n=34) e grupo diabético neuropata (GDN) (n=74). Inicialmente, foram reali zados testes para confirmação da neuropatia. Em seguida, a avaliação da atividade do sistema nervoso autônomo (SNA) foi realizada por meio da VC com o auxílio do software Nerve -Express® (Heart Rhythm Instruments, Metuchen, NJ, EUA). Já o segundo estudo, foi composto por 61 sujeitos de ambos os gêneros divididos em GC (n=32), GDN (n=18) e grupo diabético neuropata vasculopata (GDNV) (12)...
Diabetic neuropathy is characterized by clinical or sub -clinical syndrome that affects the central and peripheral nervous system including the autonomic. Tackle the growing number of 17 new cases of diabetes mellitus and the high incidence of chronic degenerative disorders, such as peripheral neuropathy and cardiovascular autonomic neuropathy, this study aimed to: a) make a comparison of heart rate variability (CV), in individuals with diabetes mellitus type 2 with confirmation of diabetic peripheral neuropathy, and healthy individuals .; b) identify the risk of falling through a functional mobility test in non -diabetic, diabetic neuropathy and diabetic neuropathy-vasculopathies. Therefore, in the first s tudy participated 108 individuals divided into a control group (CG) (n = 34) and diabetic neuropathy group (GDN) (n = 74). Initially, to confirm the neuropathy tests were performed. Then, the evaluation of the activity of the autonomic nervous system (ANS) was performed by the VC with the help of Nerve - Express® software (Heart Rhythm Instruments, Metuchen, NJ, USA). The second study consisted of 61 subjects of both genders divided into GC (n = 32), GDN (n = 18) and diabetic neuropathy vasculopata group (GDNV) (12)...
APA, Harvard, Vancouver, ISO, and other styles
7

Clifford, Rhonda Marise. "Pharmaceutical care in diabetes mellitus." Curtin University of Technology, School of Pharmacy, 2004. http://espace.library.curtin.edu.au:80/R/?func=dbin-jump-full&object_id=14951.

Full text
Abstract:
People with diabetes mellitus are more likely to die from cardiovascular causes than those without diabetes, and modifiable risk factors, such as hyperglycaemia, dyslipidaemia and hypertension can be targeted in intervention programs to decrease this risk. In addition to tertiary care for patients with diabetes, there is a need for simple programs to be implemented in the community that allow the benefits of improved metabolic and blood pressure control to be realised more widely. Pharmaceutical care comprises the detection, prevention and solution of drug-related problems in a quantifiable form, so that outcomes of care can be easily reviewed and monitored. Previous studies of pharmaceutical care programs in patients with diabetes do not provide conclusive evidence of the benefit of pharmaceutical care. The aim of this research was to evaluate the impact of the provision of pharmaceutical care to patients with diabetes mellitus in an Australian context. In order to develop a pharmaceutical care program, the characteristics of an Australian cohort of patients with diabetes were reviewed. The Fremantle Diabetes Study (FDS), was a community-based prospective observational study of diabetes care, control and complications in a postcode-defined region of 120 097 people surrounding the port city of Fremantle in Western Australia. It was intended that the FDS annual reviews would provide important local information in order to design and implement a prospective pharmaceutical care program. A pilot pharmaceutical care program was subsequently developed for use in a diabetes outpatient clinic. This program was then modified for use in a community-based sample of type 2 diabetes mellitus patients, drawn from the FDS cohort.
Demographic parameters, including ethnicity and treatment details, were reviewed at study entry for the full FDS cohort and then over time for a subset of patients that returned for four subsequent annual assessments. Insulin use was more common in patients of Southern European origin compared with the Anglo-Celt group irrespective of the level of glycaemia, at baseline. This difference persisted during subsequent follow-up but was not associated with improved glycaemic control. These findings demonstrated that there are important ethnic differences in the management of patients with type 2 diabetes mellitus. The pilot pharmaceutical care program was carried out in high-risk diabetes mellitus patients attending a hospital outpatient clinic. The patients had poor glycaemic control, dyslipidaemia, hypertension and/or were on three or more prescription medications. In the pharmaceutical care arm, a clinical pharmacist reviewed and monitored all aspects of the patients' drug therapy in collaboration with other health care professionals at six weekly intervals for six months. The control patients received usual outpatient care. Seventy-three patients were recruited into the study, of whom 48 (66%) were randomised to receive pharmaceutical care. One in six patients was taking complementary medicines. The pharmaceutical care program provided patients with important medication information that resulted in changes to drug therapy. However, the six-month program did not lead to an improvement in glycaemic control. The next phase of the study adapted the pilot hospital-based pharmaceutical care program to a community-based setting.
Two hundred and two type 2 diabetes mellitus FDS patients were recruited, of whom 101 (50%) were randomised to the pharmaceutical care program, and all were followed for 12-months. There were significant reductions in risk factors associated with coronary heart disease in the case but not the control group over time, specifically glycaemic control, lipid levels, and blood pressure. Glycosylated haemoglobin fell from 7.5% to 7.0% (P<0.0001), total cholesterol fell from 5 mmol/L to 4.6 mmol/L (P<0.0001), systolic blood pressure fell from 158 mmHg to 143 mmHg (P<0.0001) and diastolic blood pressure fell from 77mmHg to 71mmHg (P<0.0001). Multiple linear regression analysis confirmed that pharmaceutical care program involvement was an independent predictor of benefit after adjustment for key variables. The 10-year coronary heart disease risk for patients without a previous coronary event was reduced by 4.6% over the 12-month study period in the pharmaceutical care group (P<0.0001), while there was no change in the controls (P=0.23). This phase of the study showed that medium-term individualised pharmaceutical care reduced vascular risk factors in a community-based cohort of patients with diabetes and that provision of a multifactorial intervention can improve health outcomes in type 2 diabetes mellitus. As part of the pharmaceutical care program, a high level of complementary medicine use was found. As a result, a study of complementary medicine use was undertaken in 351 patients from the FDS. A convenience sample of FDS patients was interviewed regarding their use of complementary medicines. A literature search was conducted to assess the potential impact of these medicines on diabetes, concomitant medications or diabetes-related co-morbidities.
Eighty-three of 351 (23.6%) patients with diabetes had consumed at least one complementary medicine in the previous year and 42% (77/183) of the products potentially necessitated additional patient monitoring or could be considered potentially inappropriate for a diabetic patient. The data indicated the need for patient disclosure of complementary medicine use and adequate monitoring for complementary medicine-related adverse events, as part of the pharmaceutical care process. The pharmaceutical care model was established to provide a framework by which drug use could be improved to enhance patients' clinical and health-related quality of life outcomes. For the present study, a straightforward pharmaceutical care program was adapted from a hospital setting to a community setting, where the principal requirement was a clinical pharmacist who had completed a self-directed diabetes-training program. In this context, clinically relevant parameters improved over the course of the study period. Pharmaceutical care programs such as this can begin the process of translating the findings of large and expensive clinical trials into standard clinical practice.
APA, Harvard, Vancouver, ISO, and other styles
8

Sels, Jean-Pierre Joseph Emile. "Dietary fibre and diabetes mellitus." Maastricht : Maastricht : Datawyse ; University Library, Maastricht University [Host], 1991. http://arno.unimaas.nl/show.cgi?fid=5618.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chan, Juliana Chung Ngor. "Diabetes mellitus in Hong Kong." Thesis, University of Liverpool, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.246160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Talwar, D. "Glucosylated haemoglobin and diabetes mellitus." Thesis, University of Strathclyde, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.371982.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Diabetes Mellitus"

1

�zcan, Sabire. Diabetes Mellitus. New Jersey: Humana Press, 2003. http://dx.doi.org/10.1385/1592593771.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nakabeppu, Yusaku, and Toshiharu Ninomiya, eds. Diabetes Mellitus. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-3540-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bibergeil, Horst, ed. Diabetes mellitus. Vienna: Springer Vienna, 1989. http://dx.doi.org/10.1007/978-3-7091-7562-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bretzel, Reinhard G., ed. Diabetes mellitus. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74610-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kooy, Adriaan. Diabetes mellitus. Houten: Bohn Stafleu van Loghum, 2008. http://dx.doi.org/10.1007/978-90-313-6626-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Liao, Tien Ren. Diabetes mellitus. Washington, D.C: Science Reference Section, Science and Technology Division, Library of Congress, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Liao, Tien Ren. Diabetes mellitus. Washington, D.C: Science Reference Section, Science and Technology Division, Library of Congress, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

1955-, Greco Deborah Susan, and Peterson Mark E. DVM, eds. Diabetes mellitus. Philadelphia: Saunders, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

A, Rizza Robert, and Greene Douglas A, eds. Diabetes mellitus. Philadelphia: Saunders, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kishore, P. Diabetes mellitus. Barking: Directorate of Public Health, Barking & Havering Health Authority, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Diabetes Mellitus"

1

Hahn, H. J. "Tierexperimenteller Diabetes." In Diabetes mellitus, 108–17. Vienna: Springer Vienna, 1989. http://dx.doi.org/10.1007/978-3-7091-7562-0_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wolfsdorf, Joseph I., and Mark A. Sperling. "Diabetes Mellitus." In Textbook of Clinical Pediatrics, 3759–89. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_387.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Maggi, Stefania, and Nicola Veronese. "Diabetes Mellitus." In Practical Issues in Geriatrics, 117–22. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-61997-2_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bährle-Rapp, Marina. "Diabetes mellitus." In Springer Lexikon Kosmetik und Körperpflege, 151. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-71095-0_2828.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Riesenberg, Don. "Diabetes Mellitus." In Geriatric Medicine, 228–38. New York, NY: Springer New York, 1990. http://dx.doi.org/10.1007/978-1-4757-2093-8_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Smith, Charles Kent, John P. Sheehan, and Margaret M. Ulchaker. "Diabetes Mellitus." In Family Medicine, 1649–68. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04414-9_127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Michels, G., C. Schumann, and M. Faust. "Diabetes mellitus." In Klinikmanual Innere Medizin, 594–610. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-89110-9_70.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Al Hamarneh, Yazid N., Rick L. Siemens, Kendra J. Townsend, and Ross T. Tsuyuki. "Diabetes Mellitus." In Patient Assessment in Clinical Pharmacy, 157–70. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-11775-7_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Geigges, Werner, Ulrich Garwers, Martin Poppelreuter, and Kurt Fritzsche. "Diabetes mellitus." In Psychosomatische Grundversorgung, 175–83. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-47744-1_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Shillitoe, Richard. "Diabetes mellitus." In Health Psychology, 187–204. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-3226-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Diabetes Mellitus"

1

Ammutammima, Ummu Fatihah, Didik Gunawan Tamtomo, and Bhisma Murti. "Family History with Diabetes Mellitus and the Gestational Diabetes Mellitus: Meta-Analysis." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.05.54.

Full text
Abstract:
Background: Gestational diabetes mellitus (GDM) is a major public health problem because of its associated complications during pregnancy. Studies have suggested that women with positive parental history of diabetes may be predisposed to an increased GDM risk. This study aimed to examine the correlation between family history with diabetes mellitus and the gestational diabetes mellitus. Subjects and Method: This was a meta-analysis and systematic review. The study was collected articles from PubMed, Science Direct, and Google Scholar databases, from year 2017 to 2020. Keywords used “gestational diabetes mellitus” OR “GDM” AND “pregnancy induced diabetes” AND “family history of diabetes” AND “crosssectional”. The study subject was pregnant women. Intervention was family history with diabetes mellitus with comparison no family history of diabetes mellitus. The study outcome was gestational diabetes mellitus. The articles were selected by PRISMA flow chart. The quantitative data were analyzed by ReVman 5.3. Results: 7 studies from Kuwait, Ethiopia, Fiji, Malaysia, and China, reported that family history with diabetes mellitus increased the risk of gestational diabetes mellitus (aOR= 1.68; 95% CI= 0.87 to 3.26; p= 0.120). Conclusion: Family history with diabetes mellitus increases the risk of gestational diabetes mellitus. Keywords: gestational diabetes mellitus, pregnancy induced diabetes, family history of diabetes Correspondence: Ummu Fsatihah Ammutammima. Masters Program Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: ummuftha64@gmail.com. Mobile: 081717252573. DOI: https://doi.org/10.26911/the7thicph.05.54
APA, Harvard, Vancouver, ISO, and other styles
2

Assunção Júnior, José Lima, Michelle Paz de Araújo, Ana Luiza de Mello Leão Oliveira, Júlia Assis Gonçalves, Isadora Villamarim Guerra Borges, Luan Figueiredo Rodrigues, Raquel Melo Vasconcelos, et al. "Diabetes mellitus tipo 1." In II SEVEN INTERNATIONAL MEDICAL AND NURSING CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/iicongressmedicalnursing-185.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Akeel Hamed AL-OEBADY, Mouna, Hedaa M.NAHAB, and Suhair M.JABBAR. "THE CORRELATION BETWEEN COVID-19 AND DIABETES MELLITUS." In V. International Scientific Congress of Pure, Applied and Technological Sciences. Rimar Academy, 2022. http://dx.doi.org/10.47832/minarcongress5-19.

Full text
Abstract:
COVID-19 and diabetes mellitus have a complicated relationship. Diabetes was first of the most significant risk factors for severe COVID-19 therapy. The link between COVID-19 and diabetes was investigated in this study utilizing data from the Martyr Yousuf Hospital in the Al-Muthanaa region. The data was divided into three groups: T1D (n = 641), T2D (n = 477), and normal (non-diabetic cases, n = 1745) males and females of different ages. The findings show a strong positive association coefficient of 0.8165 between infection with COVID-19 and age in 641 patients with diabetes mellitus type I, with a P-Value of 0.00001 at p 0.05, but a poor relationship between infection with covid-19 and gender.
APA, Harvard, Vancouver, ISO, and other styles
4

Sitorukmi, Galuh, Bhisma Murti, and Yulia Lanti Retno Dewi. "Effect of Family History with Diabetes Mellitus on the Risk of Gestational Diabetes Mellitus: A Meta-Analysis." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.05.55.

Full text
Abstract:
Background: Gestational diabetes mellitus (GDM) is a serious pregnancy complication, in which women without previously diagnosed diabetes develop chronic hyperglycemia during gestation. Studies have revealed that the family history of diabetes is an important risk factor for the gestational diabetes mellitus. The purpose of this study was to investigate effect of family history with diabetes mellitus on the risk of gestational diabetes mellitus. Subjects and Method: This was meta-analysis and systematic review. The study was conducted by collecting published articles from Pubmed, Google Scholar, Scopus, Science Direct, and Springer Link electronic databases, from year 2010 to 2020. Keywords used risk factor, gestational diabetes mellitus, family history, and cross-sectional. The inclusion criteria were full text, using English language, using cross-sectional study design, and reporting adjusted odds ratio. The study population was pregnant women. Intervention was family history of diabetes mellitus with comparison no family history of diabetes mellitus. The study outcome was gestational diabetes mellitus. The collected articles were selected by PRISMA flow chart. The quantitative data were analyzed by random effect model using Revman 5.3. Results: 7 studies from Ethiopia, Malaysia, Philippines, Peru, Australia, and Tanzania were selected for this study. This study reported that family history of diabetes mellitus increased the risk of gestational diabetes mellitus 2.91 times than without family history (aOR= 2.91; 95% CI= 2.08 to 4.08; p<0.001). Conclusion: Family history of diabetes mellitus increases the risk of gestational diabetes mellitus. Keywords: gestational diabetes mellitus, diabetes mellitus, family history Correspondence: Galuh Sitorukmi. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: galuh.sitorukmi1210@gmail.com. Mobile: 085799333013. DOI: https://doi.org/10.26911/the7thicph.05.55
APA, Harvard, Vancouver, ISO, and other styles
5

Alava, I., L. J. Garcia Frade, H. de la Calle, J. L. Havarro, L. J. Creighton, and P. J. Gaffney. "DIABETES MELLITUS: HYPERCOAGULABILITY AID HYPOFIBRIHOLYSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643108.

Full text
Abstract:
A hypercoagulable state has been related to the presence of microvascular and macrovascular disease in Diabetes Mellitus. The aim of this study was to establish when this hypercoagulable state appears and the response of the fibrinolytic system.43 patients (29 males, 14 females, aged 19-73), 28 insulin-dependent (10 of them with micro and/or macrovascular disease), 15 non insulin- dependent (all of them with vascular disease) were studied.Platelet aggregation and adenine nucleotides, plasma and serum thromboxane B2 (TxB2), Factor VIII Coagulant (VIII-C), Factor VIII Related antigen (VIII-RAg), Factor VIII Ristocetin Cofactor (VIII-RCoF), Fibronectin, Tissue Plasminogen Activator (t-PA) and X-Oligomers fibrin fragments were measured.In the diabetic patients maximal aggregation was induced by a threshold concentration of adenosin diphosphate and arachidonic acid lower than in controls (p<0.01 and p<0.05). Diabetic patients also presented elevated platelet ADP and decreased platelet c-AMP. They had higher plasma TxB* levels than the control group.FVIII-C, FVIII-RAg and Fibronectin were increased (p<0.001) both in patients type I and II, with and without vasculopathy. FVIII-RCoF was highly increased in vasculopathy (p<0.001) while was non significant without it.The patients with vasculopathy presented decreased t-PA plasma levels (p<0.05). lo difference in X-Oligomers was found related to controls.These findings suggest: 1) A hypercoagulable state previously to the development of clinical vasculopathy. 2) A decreased fibrinolytic response associated to vasculopathy.
APA, Harvard, Vancouver, ISO, and other styles
6

Elcin, Huseyn. "EARLY IDENTIFICATION OF THE NEUROLOGICAL COMPLICATIONS OF DIABETES MELLITUS." In International Trends in Science and Technology. RS Global Sp. z O.O., 2021. http://dx.doi.org/10.31435/rsglobal_conf/30032021/7474.

Full text
Abstract:
Diabetes mellitus is still a very common disease in the world and affects the daily lives of patients negatively. Diabetes is also known to be associated with neurological diseases such as peripheral nerve diseases, stroke and dementia. Among these, the most common disease is a peripheral nerve disease, and it has been reported that poor diabetic control increases the risk of development and can be prevented by education of the patients. Vascular dementia is more common in patients with diabetes than Alzheimer's disease, and it is thought that cerebrovascular diseases may berelated to cognitive impairment in diabetes. Although the mechanisms by which diabetes affects the brain are not clearly revealed, it is thought that changes in vascular structure, insulin resistance, glucose toxicity, oxidative stress, accumulation of glycation end products, hypoglycemic episodes and amyloid metabolism are effective.The aim of this article is to describe the neurological complications of diabetes and to emphasize the importance of patient education, good diabetes control and early diagnosis in preventing these complications.
APA, Harvard, Vancouver, ISO, and other styles
7

Mustafa, Wafaa Yusuf. "45 Diabetes mellitus and dermatomyositis." In The 7th ASPED-ISPAD Diabetes Academy. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/bmjpo-2024-asped.45.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Vasil'ceva, O. YA, and K. N. Vitt. "Diabetes mellitus and thrombotic complications." In Scientific dialogue: Medical issues. ЦНК МОАН, 2019. http://dx.doi.org/10.18411/spc-15-05-2019-07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Eppstein, Jonathan A., and Sven-Erik Bursell. "Noninvasive detection of diabetes mellitus." In OE/LASE '92, edited by Thomas S. Mang. SPIE, 1992. http://dx.doi.org/10.1117/12.59364.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hilario, Maria João Pimenta, and SERGIO FILIPE VALERIO. "RASTREIO DIABETES MELLITUS ALTO ALENTEJO." In Congresso Brasileiro de Pesquisas e Análises Clínicas On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/conaclil/12916.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Diabetes Mellitus"

1

Pillay, Jennifer, Pritam Chordiya, Sanjaya Dhakal, Ben Vandermeer, Lisa Hartling, Marni J. Armstrong, Sonia Butalia, et al. Behavioral Programs for Diabetes Mellitus. Agency for Healthcare Research and Quality, September 2015. http://dx.doi.org/10.23970/ahrqepcerta221.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Vakhlova, Irina, Irina Zaikova, Alexey Kiyaev, and Yulia Ibragimova. Electronic educational resource (EOR) "Module. Diabetes mellitus in children". SIB-Expertise, January 2024. http://dx.doi.org/10.12731/er0781.29012024.

Full text
Abstract:
Diabetes mellitus occupies a leading place in the pathology of the endocrine system in children and adolescents and remains one of the most urgent health problems in most countries. In the last decade, the annual incidence of type 1 diabetes in children has shown a significant increase both in Russia and around the world. According to the International Diabetes Federation (IDF), it is increasing by 3% per year. In addition, in all European countries there is a "phenomenon of rejuvenation of diabetes" - an increase in the proportion of children who first fell ill with type 1 diabetes at a younger age: 25-30% up to 4 years of age; up to 80% - from 6 months to 9 years. The annual incidence of type 1 diabetes in children (0-14 years old) in the Sverdlovsk region over the past decade (2006-2017) has almost doubled: from 12.2 cases per 100 thousand children in 2006 to 23 ,7 in 2017 and occupies one of the leading places in the Russian Federation in this indicator. More than 200 children with type 1 diabetes are diagnosed per year, of which about 75% of children who become ill for the first time are under the age of 9 years. Type 1 diabetes is characterized by complete insulin dependence, severe course, early formation of specific complications that lead to a decrease in the quality and life expectancy. Unfortunately, in more than 70% of cases, DM is diagnosed at the stage of ketoacidosis, which requires urgent measures. The main reason for the late diagnosis of this disease is the lack of "diabetic alertness" among pediatricians and AFP physicians. The foregoing obliges a wide range of doctors, including pediatricians, to know the clinical and laboratory criteria for diagnosis, modern methods of monitoring and managing diabetes, possible complications and outcomes of the disease, and be able to provide emergency care. Timely diagnosis, self-monitoring, regular monitoring, prevention of complications is an opportunity to improve the quality of life of patients with diabetes.
APA, Harvard, Vancouver, ISO, and other styles
3

Moya Hernández, Alejandro, and Martín Aldasoro Celaya. Resistencia a la insulina y su relación con la Enfermedad de Alzheimer. Fundación Avanza, May 2023. http://dx.doi.org/10.60096/fundacionavanza/2002022.

Full text
Abstract:
En este artículo se han tratado de revisar y unificar las últimas investigaciones en las que se ha propuesto que la Enfermedad de Alzheimer puede representar una forma cerebro-específica de Diabetes Mellitus, la Diabetes Mellitus tipo 3.
APA, Harvard, Vancouver, ISO, and other styles
4

Wang, Wei, and Yi Wu. Prediction models for diabetic retinopathy development in type 2 diabetes mellitus patients: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0089.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gregory, Elizabeth, and Danielle Ely. Trends and Characteristics in Prepregnancy Diabetes: United States, 2016–2021. National Center for Health Statistics (U.S.), May 2023. http://dx.doi.org/10.15620/cdc:127679.

Full text
Abstract:
This report presents data on trends for prepregnancy diabetes mellitus (PDM), diabetes diagnosed before pregnancy, in mothers giving birth in the United States for 2016–2021, and rates by selected maternal characteristics for 2016 and 2021.
APA, Harvard, Vancouver, ISO, and other styles
6

Silva, Rodrigo Ribeiro e., Mateus de Miranda Gauza, Julia Opolski Nunes da Silva Opolski, and Maria Eduarda Schramm Guisso. Once-Weekly Insulin Icodec vs Once-Daily Insulin Glargine U100 for Type 2 Diabetes: A Meta-analysis of Phase 2 Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0102.

Full text
Abstract:
Review question / Objective: To compare Once-Weekly Insulin Icodec and Once-Daily Insulin Glargine U100 in patients with Type 2 Diabetes Mellitus using oral hypoglycemic drugs in need of insulin therapy. Condition being studied: Patients with Diabetes Mellitus Type 2 using oral hypoglycemic drugs in need for basal insulin. Eligibility criteria: Inclusion in this meta-analysis was restricted to studies that met all the following criteria: (1) randomized trials; (2) comparing the use once weekly insulin icodec to once daily insulin glargine; (3) enrolling patients with type 1 or type 2 diabetes mellitus; (4) evaluating any of the desired outcomes; (4) articles in written on english language. We excluded studies with (1) no control group; (2) overlapping studies population; clinical trial register entry only; (3) non-human studies and (4) studies reported only as abstracts.
APA, Harvard, Vancouver, ISO, and other styles
7

Norris, John, Robin Gordon, Margaret Harvey, and Laura Reed. Utilization of Depression Screening in Patients with Type 2 Diabetes Mellitus. University of Tennessee Health Science Center, May 2024. http://dx.doi.org/10.21007/con.dnp.2024.0095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sosa Munguía, Paulina del Carmen, Verónica Ajelet Vargaz Guadarrama, Marcial Sánchez Tecuatl, Mario Garcia Carrasco, Francesco Moccia, and Roberto Berra-Romani. Diabetes mellitus alters intracellular calcium homeostasis in vascular endothelial cells: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0104.

Full text
Abstract:
Review question / Objective: What are the effects of diabetes mellitus on the calcium homeostasis in vascular endothelial cells? -To describe the effects of diabetes on the mechanisms that regulate intracellular calcium; -To describe other molecules/mechanisms that alters intracellular Ca2+ homeostasis. Condition being studied: Diabetes mellitus is a pathology with a high incidence in the population, characterized by an increase in blood glucose. People with diabetes are 2-4 times more likely to suffer from a cardiovascular complication, such as total or partial loss of sight, myocardial infarction, kidney failure, among others. Cardiovascular complications have been reported to derive from dysfunction of endothelial cells, which have important functions in blood vessels. In order to understand the etiology of this poor function of endothelial cells, it is necessary to study the molecular mechanisms involved in these functions, to identify the effects of diabetes and thus, develop new research that will mitigate the effects of this pathology.
APA, Harvard, Vancouver, ISO, and other styles
9

Fu, Shouqiang, Liwei Zhang, Xiaoyun Zhu, and Ximing Liu. Associating Abdominal Obesity with Diabetic Retinopathy in Patients with Diabetes Mellitus: Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0091.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Amador-Munoz, Diana Patricia, and Stefany Hernández. En el ‘ojo’ de la diabetes. Universidad del Rosario, November 2022. http://dx.doi.org/10.12804/dvcn_10336.36855_num6.

Full text
Abstract:
La diabetes mellitus es considerada como una de las enfermedades crónicas más alarmantes del siglo XXI. De no ser tratada correctamente, los pacientes pueden presentar daños en distintos órganos, entre ellos, los ojos. Un reciente estudio de la Universidad del Rosario encontró que la córnea, además de la retina, también se deteriora en los casos de diabetes, y en los pacientes con el Tipo 1 se lesiona más rápido que en los pacientes con el Tipo 2.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Diabetes Mellitus' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography